Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patterson

Showing results (521-530 of 599) with videos related to

Pageof 60
Sort By:
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2008
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosisD P Kontoyiannis, V Ratanatharathorn, J-A Young, et al.
Journal of Clinical Microbiology|January 22, 2016
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal ModelP Lewis White, Nathan P Wiederhold, Juergen Loeffler, et al.
Journal of Clinical Microbiology|November 24, 1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerS W Redding, R C Zellars, W R Kirkpatrick, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2020
Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infectionMeghan H Shilts, Christian Rosas-Salazar, Kedir N Turi, et al.
Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Clinical Microbiology Reviews|July 13, 2023
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and ManagementGeorge R Thompson, Jeffrey D Jenks, John W Baddley, et al.
Infection and Immunity|December 30, 2016
The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratumJennifer L Reedy, Paige E Negoro, Marianela Feliu, et al.
Pageof 60

Showing results (521-530 of 599) with videos related to

Sort By:
Pageof 60
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 6, 2008
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosisD P Kontoyiannis, V Ratanatharathorn, J-A Young, et al.
Journal of Clinical Microbiology|January 22, 2016
Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal ModelP Lewis White, Nathan P Wiederhold, Juergen Loeffler, et al.
Journal of Clinical Microbiology|November 24, 1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerS W Redding, R C Zellars, W R Kirkpatrick, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2020
Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infectionMeghan H Shilts, Christian Rosas-Salazar, Kedir N Turi, et al.
Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Clinical Microbiology Reviews|July 13, 2023
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and ManagementGeorge R Thompson, Jeffrey D Jenks, John W Baddley, et al.
Infection and Immunity|December 30, 2016
The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratumJennifer L Reedy, Paige E Negoro, Marianela Feliu, et al.
Pageof 60